Cargando…

基于代谢组学的多西他赛调控肺癌细胞代谢重编程研究

BACKGROUND AND OBJECTIVE: Docetaxel is a commonly used anti-tumor drug in clinic, especially as the first-line drug for advanced non-small cell lung cancer (NSCLC). However, the molecular mechanism of docetaxel against NSCLC is still unclear. Increasing studies have shown that metabolic reprogrammin...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500501/
https://www.ncbi.nlm.nih.gov/pubmed/31014438
http://dx.doi.org/10.3779/j.issn.1009-3419.2019.04.02